Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003 Gene Therapy for the…
<!-- Name:DistributionId Value:8741270 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4533 -->…
Browsing Tag
Opthalmology
Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03…
Saturn-1 Phase 2b/3 trial met all primary and secondary endpoints, and demonstrated significant, clinically meaningful outcomes with no serious treatment-related adverse events and no treatment-related discontinuations, demonstrating the…